Natriuretic peptides and the Framingham risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study

Int J Cardiol. 2013 Oct 12;168(5):5093-5. doi: 10.1016/j.ijcard.2013.07.260. Epub 2013 Aug 3.
No abstract available

Keywords: Asymptomatic left ventricular systolic dysfunction; Cardiovascular risk; Heart failure; Natriuretic peptide; Primary care; Screening.

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Asymptomatic Diseases* / epidemiology
  • Biomarkers / blood
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Natriuretic Peptides / blood*
  • Primary Health Care / methods*
  • Prospective Studies
  • Risk Factors
  • Ventricular Dysfunction, Left / blood*
  • Ventricular Dysfunction, Left / diagnosis*
  • Ventricular Dysfunction, Left / epidemiology

Substances

  • Biomarkers
  • Natriuretic Peptides